Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Pharma DTC Spend Increasing At Twice The Rate Of Physician Promotions, GAO Finds

This article was originally published in The Pink Sheet Daily

Executive Summary

A Government Accountability Office report, released Dec. 14, calls for improvements in FDA’s oversight of direct-to-consumer advertising.

You may also be interested in...



FDA Shows Limited Progress In Managing DTC Workload, GAO Tells House Panel

House Energy and Commerce panel hearing focuses on DTC ads for Vytorin, Lipitor and Procrit.

FDA Shows Limited Progress In Managing DTC Workload, GAO Tells House Panel

House Energy and Commerce panel hearing focuses on DTC ads for Vytorin, Lipitor and Procrit.

User Fee Deal For Ad Review Funds Stems From PhRMA DTC Principles

The draft proposal is expected to be a stand-alone clause, not technically part of next year's reauthorization of the Prescription Drug User Fee Act.

Topics

UsernamePublicRestriction

Register

MT142639

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel